Processing 00000000.tx.1: Distortion of allelic expression of apolipoprotein E in Alzheimer's disease Jean-Charles Lambert1,2, Jordi Prez-Tur1,3, Marie-Jolle Dupire1, Douglas Galasko4, David Mann5, Philippe Amouyel2, John Hardy3, Andr Delacourte1, Marie-Christine Chartier-Harlin1,2,* 1INSERM Unit 422, Place de Verdun, 59045 Lille Cedex, France, 2INSERM CJF95-05, Institut Pasteur de Lille, 1 rue de Calmette, 59019 Lille Cedex, France, 3Birdsall Building, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA, 4UCSD, Medical Centre, Pulman Ambulatory Care Centre, 9350 Campus Point Drive, La Jolla, CA 92037, USA and 5Department of Pathological Sciences, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK Received July 25, 1997; 

Phrase: "Distortion of allelic expression of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332482:Distortion [Anatomical Abnormality]
   748   C2919017:Distortion [Qualitative Concept]

Phrase: "in Alzheimer's disease Jean-Charles Lambert1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Jordi Prez-Tur1,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Marie-Jolle Dupire1,"

Phrase: "Douglas Galasko4,"

Phrase: "David Mann5,"

Phrase: "Philippe Amouyel2,"

Phrase: "John Hardy3,"

Phrase: "Andr Delacourte1,"

Phrase: "Marie-Christine Chartier-Harlin1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "* 1INSERM Unit 422,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "Place de Verdun,"

Phrase: "59045 Lille Cedex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0591239:Cedex [Antibiotic,Organic Chemical]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "2INSERM CJF95-05,"

Phrase: "Institut Pasteur de Lille,"

Phrase: "1 rue de Calmette,"

Phrase: "59019 Lille Cedex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0591239:Cedex [Antibiotic,Organic Chemical]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "3Birdsall Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "4500 San Pablo Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Jacksonville,"

Phrase: "FL 32224,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "4UCSD,"

Phrase: "Medical Centre,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
  1000   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0205099:Center [Spatial Concept]
   861   C0205476:Medical [Functional Concept]

Phrase: "Pulman Ambulatory Care Centre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "9350 Campus"

Phrase: "Point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "Drive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92037,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "5Department of Pathological Sciences,"

Phrase: "Stopford Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547706:Building [Functional Concept]
   861   C1999269:Building [Manufactured Object]

Phrase: "University of Manchester,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oxford Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Manchester M13 9PT,"

Phrase: "UK"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "July 25,"

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted August 2, 1997 The APOE [epsis]4 allele is a strong genetic susceptibility factor for Alzheimer's disease. 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted August 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1997"

Phrase: "The APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "a strong genetic susceptibility factor for Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   767   C0679238:disease factor [Functional Concept]
   767   C0960756:factor A [Organic Chemical]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.3: Interaction with other biological factors may modulate the effect of the apoE isoforms. 

Phrase: "Interaction with other biological factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the effect of the apoE isoforms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.4: However, previous work suggested that other genetic variability within the APOE locus, influencing the effect of the [epsis]4 allele, may exist. 

Phrase: "However,"

Phrase: "previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other genetic variability within the APOE locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2827666:Variability [Conceptual Entity]

Phrase: "influencing"

Phrase: "the effect of the [epsis]4 allele,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.5: Such variability could modify the expression of the APOE gene and, in particular, the level of expression of APOE alleles could be an important determinant of disease pathogenesis. 

Phrase: "Such variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2827666:Variability [Conceptual Entity]
   928 E C0439828:Variable [Qualitative Concept]

Phrase: "could"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the expression of the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: ","

Phrase: "in particular,"

Phrase: "the level of expression of APOE alleles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3244092:expression level [Idea or Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "an important determinant of disease pathogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.6: To test this hypothesis we examined the levels of expression of APOE in heterozygotes with AD and in controls, using a new method of semi-quantitation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the levels of expression of APOE"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "with AD"

Phrase: "and in controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1515981:And [Idea or Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a new method of semi-quantitation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.7: We report that relative [epsis]4 mRNA expression is increased in AD compared with controls and suggest that genetic variability in the neural expression of APOE contributes to disease risk. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that relative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080103:Relative [Family Group]
  1000   C0205345:Relative [Qualitative Concept]
  1000   C1547039:*Relative [Quantitative Concept]

Phrase: "[epsis]4 mRNA expression"

Phrase: "is"

Phrase: "increased in AD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that genetic variability in the neural expression of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C2827666:Variability [Conceptual Entity]
   726   C1868500:Variable expression [Finding]

Phrase: "contributes to disease risk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.8: INTRODUCTION The [epsis]4 allele of the APOE gene is a major risk factor for late-onset Alzheimer's disease (LOAD) (1), and is also implicated as a risk factor for early-onset disease in some populations (2,3). 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The [epsis]4 allele of the APOE gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1370079:APOE Gene Allele 4 [Gene or Genome]
   784   C3642141:APOE*4 Allele [Gene or Genome]
   742   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "is"

Phrase: "a major risk factor for late-onset Alzheimer's disease (LOAD)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   784   C0850664:disease risk factor [Finding]
   764   C0035648:Risk factor [Quantitative Concept]
   762   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   762   C0679238:disease factor [Functional Concept]
   762   C0960756:factor A [Organic Chemical]
   762   C1281905:disease risk [Finding]
   742   C0035647:Risk [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "also"

Phrase: "implicated as a risk factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035648:Risk factor [Quantitative Concept]
   797   C0960756:factor A [Organic Chemical]
   760   C0035647:Risk [Qualitative Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "for early-onset disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0679245:early disease [Temporal Concept]
   901   C1833334:Early-onset [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "in some populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.9: Previous studies have described [epsis]4 homozygotes as having a higher risk of developing disease than [epsis]3[epsis]4 heterozygotes. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "[epsis]4 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019904:Homozygotes [Organism Attribute]

Phrase: "as"

Phrase: "having"

Phrase: "a higher risk of developing disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   816   C0332167:High risk of [Qualitative Concept]
           High Risk
   783   C1281905:disease risk [Finding]
   756   C3272283:High Risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "[epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 heterozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019425:Heterozygotes [Organism Attribute]
Processing 00000000.tx.10: However, individuals bearing one or two [epsis]4 alleles, do not inevitably develop the disease. 

Phrase: "However,"

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "[epsis]4 alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "do"

Phrase: "not inevitably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "develop"

Phrase: "the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.11: Detailed genetic analysis around the APOE locus has suggested the existence of other genetic variability in this region which could contribute to disease risk (4). 

Phrase: "Detailed genetic analysis around the APOE locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0679560:genetic analysis [Laboratory Procedure]
   778   C0796344:Genetic Analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of other genetic variability"

Phrase: "in this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "which"

Phrase: "could"

Phrase: "contribute to disease risk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.12: There are two possible explanations for these observations: (i) there is another genetically variable locus in the vicinity of the APOE gene involved in the pathogenesis of the disease; 

Phrase: "There"

Phrase: "are"

Phrase: "two possible explanations for these observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanations [Intellectual Product]

Phrase: ":"

Phrase: "(i) there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "another genetically variable locus in the vicinity of the APOE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1708726:Gene Locus [Gene or Genome]
           Locus

Phrase: "involved in the pathogenesis of the disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012634:Disease [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]

Phrase: ";"
Processing 00000000.tx.13: (ii) there is a genetic variability in the control of expression of the APOE gene (4). 

Phrase: "(ii"

Phrase: ")"

Phrase: "there"

Phrase: "is"

Phrase: "a genetic variability in the control of expression of the APOE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C2827666:Variability [Conceptual Entity]
   715   C0683951:control variable [Quantitative Concept]
   715   C1868500:Variable expression [Finding]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.14: There has been little examination of the mRNA expression of APOE in AD (5,6). 

Phrase: "There"

Phrase: "has"

Phrase: "been"

Phrase: "little examination of the mRNA expression of APOE"

Phrase: "in AD (5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050718:AD 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.15: The available evidence suggests that APOE expression is increased by neuronal damage (7,8) and that the bulk of the expression occurs in astrocytes (5). 

Phrase: "The available evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that APOE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "increased by neuronal damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010957:Damage [Injury or Poisoning]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1883709:Damage [Functional Concept]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "the bulk of the expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012173:Bulk [Food]
   760   C1337615:Bulk [Biomedical or Dental Material]

Phrase: "occurs in astrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0004112:Astrocytes [Cell]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.16: This expression is believed to be part of a compensatory mechanism aimed at aiding reafferentation and reactive synaptogenesis (9). 

Phrase: "This expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "part of a compensatory mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "aimed at aiding reafferentation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   737   C0018896:Aid [Social Behavior]
   737   C0449435:Aid [Manufactured Object]
   737   C1947946:Aim [Idea or Concept]
   737   C2948600:Aim [Pharmacologic Substance]
   737   C3540469:AID [Gene or Genome]
   737   C3540471:AIM [Gene or Genome]
   737   C3540472:AIM [Functional Concept]

Phrase: "and"

Phrase: "reactive synaptogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597545:synaptogenesis [Organ or Tissue Function]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.17: Only a few studies have examined the expression of the apoE protein in AD cases and controls relative to the APOE genotype (9,10). 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the expression of the apoE protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "relative to the APOE genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.18: Bertrand et al. have suggested that the amount of apoE protein could be inversely correlated to the number of [epsis]4 alleles carried by subjects: higher levels were observed in [epsis]3 homozygotes, lower in [epsis]4 homozygotes and intermediate levels in [epsis]3[epsis]4 heterozygotes (10). 

Phrase: "Bertrand et al."

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the amount of apoE protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "inversely"

Phrase: "correlated to the number of [epsis]4 alleles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0002085:Alleles [Gene or Genome]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1707520:Correlated [Qualitative Concept]

Phrase: "carried by subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0206243:carried [Activity]
   790   C0699809:carried [Finding]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: ":"

Phrase: "higher levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in [epsis]3 homozygotes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0019904:Homozygotes [Organism Attribute]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "in [epsis]4 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0019904:Homozygotes [Organism Attribute]

Phrase: "and"

Phrase: "intermediate levels in [epsis]3"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   859   C0456949:Level 3 [Intellectual Product]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   799   C0205103:Intermediate [Spatial Concept]
   799   C0441889:Levels [Qualitative Concept]
   799   C1550465:intermediate [Idea or Concept]
   799   C2827755:INTERMEDIATE [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "[epsis]4 heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019425:Heterozygotes [Organism Attribute]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.19: We hypothesised that, since [epsis]4 homozygotes have a higher risk of developing disease than [epsis]3[epsis]4 heterozygotes, and a high proportion of individuals with the latter genotype reach a greater age without developing AD, a likely explanation of this was that there was genetic variability in neural expression at the APOE locus and that [epsis]3[epsis]4 heterozygote individuals who were high [epsis]4 expressors and/or low [epsis]3 expressors were more likely to develop AD than individuals with high [epsis]3 expressors and/or low [epsis]4 expressors. 

Phrase: "We"

Phrase: "hypothesised"

Phrase: "that,"

Phrase: "since"

Phrase: "[epsis]4 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019904:Homozygotes [Organism Attribute]

Phrase: "have"

Phrase: "a higher risk of developing disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   816   C0332167:High risk of [Qualitative Concept]
           High Risk
   783   C1281905:disease risk [Finding]
   756   C3272283:High Risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "[epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 heterozygotes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "a high proportion of individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "with the latter genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "a greater age without developing AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0001779:Age [Organism Attribute]

Phrase: "a likely explanation of this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "was"

Phrase: "that there"

Phrase: "was"

Phrase: "genetic variability in neural expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1868500:Variable expression [Finding]
   760   C2827666:Variability [Conceptual Entity]

Phrase: "at the APOE locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "[epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 heterozygote individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0027361:Individual [Population Group]
   771   C0237401:Individual [Human]

Phrase: "who"

Phrase: "were"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "[epsis]4 expressors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0491816:EXPRESSOR [Medical Device]

Phrase: "and/or"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "[epsis]3 expressors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0491816:EXPRESSOR [Medical Device]

Phrase: "were"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "develop"

Phrase: "AD than individuals"

Phrase: "with high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "[epsis]3 expressors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0491816:EXPRESSOR [Medical Device]

Phrase: "and/or"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "[epsis]4 expressors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0491816:EXPRESSOR [Medical Device]
Processing 00000000.tx.20: The identification of the APOE allele transcription products is easily achieved by RT-PCR, using restriction fragment length polymorphism. 

Phrase: "The identification of the APOE allele transcription products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "is"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "achieved by RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "restriction fragment length polymorphism."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   812   C0032529:Polymorphism [Genetic Function]
   812   C0332255:fragment [Functional Concept]
   812   C0443288:Restriction [Functional Concept]
   812   C1444754:Length [Quantitative Concept]
   812   C1706316:LENGTH [Research Activity]
   812   C1708096:Fragment [Qualitative Concept]
   812   C1882417:Polymorphism [Qualitative Concept]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.21: We developed a semi-quantitative assay to measure allelic expression of APOE mRNA by RT-PCR using silver staining (11). 

Phrase: "We"

Phrase: "developed"

Phrase: "a semi-quantitative assay to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "allelic expression of APOE mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1515670:mRNA Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.22: This method of quantitation has been applied to brains of heterozygote subjects collected at various centres and used to assess the percentage of [epsis]4 mRNA expression in [epsis]3[epsis]4 and [epsis]2[epsis]4 subjects and [epsis]2 mRNA expression in [epsis]2[epsis]3 individuals. 

Phrase: "This method of quantitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "applied to brains of heterozygote subjects"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0019425:Heterozygote [Organism Attribute]
   753   C0185125:Applied [Health Care Activity]
   719   C0681850:Subject [Group]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]
   719   C1550501:{Subject} [Idea or Concept]
   719 E C1632850:Apply [Functional Concept]
   719   C1706203:Subject [Idea or Concept]
   719 E C1879355:Apply [Functional Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "collected at various centres"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205099:centres [Spatial Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the percentage of [epsis]4 mRNA expression in [epsis]3"

Phrase: "[epsis]4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "and ["

Phrase: "epsis]2 mRNA expression in [epsis]2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]3 individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
Processing 00000000.tx.23: This has been carried out both in AD cases and controls. 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "both in AD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0238767:Both [Spatial Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1706086:Both [Qualitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.24: RESULTS We selected a series of [epsis]3[epsis]4, [epsis]2[epsis]4, [epsis]2[epsis]3 AD cases (n = 14) and controls (n = 12) in order to measure the relative level of expression of the APOE allele in the frontal cortex (Fig. 1). 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "We"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "a series of [epsis]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0205549:Series [Quantitative Concept]
   804   C2348044:Series [Intellectual Product]

Phrase: "[epsis]4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]3 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "(n = 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(n = 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the relative level of expression of the APOE allele"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C3244092:expression level [Idea or Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "in the frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.25: We observed that [epsis]3 mRNA expression was consistently greater than [epsis]4 mRNA expression in all cases (Fig. 2). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "[epsis]3 mRNA expression"

Phrase: "was"

Phrase: "consistently greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "[epsis]4 mRNA expression in all cases"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.26: In addition, there was a clear and consistent difference in the [epsis]4 allelic expression ratio between AD cases and controls (Fig. 2), with AD cases showing a higher relative expression of [epsis]4 mRNA than controls (34.4  2.6% versus 22.6  1.8%, respectively, P = 0.001 with Mann-Whitney test). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "was"

Phrase: "a clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "consistent difference in the [epsis]4 allelic expression ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "between AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "with AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a higher relative expression of [epsis]4 mRNA than controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1515670:mRNA Expression [Genetic Function]
   738   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(34.4  2.6%"

Phrase: "versus"

Phrase: "22.6  1.8%,"

Phrase: "respectively,"

Phrase: "P = 0.001 with Mann-Whitney test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1708930:Mann-Whitney Test [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0392366:test [Intellectual Product]
   748   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.27: Regarding the other heterozygous genotypes, the small size of each group prevented us from reaching any definite conclusion. 

Phrase: "Regarding"

Phrase: "the other heterozygous genotypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0019425:heterozygous genotype [Organism Attribute]
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "the small size of each group"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0748864:small size [Finding]
   783   C0237884:group size [Group Attribute]
   783   C0679993:small group [Group Attribute]
   753   C0456389:size [Spatial Concept]
   753   C0700321:Small [Quantitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "us from reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2584321:Reaching [Organism Function]

Phrase: "any definite conclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusion [Idea or Concept]
Processing 00000000.tx.28: Nevertheless, a trend towards the same situation as observed in the [epsis]3[epsis]4 group could be noted, an increase in the expression of the [epsis]4 allele in the [epsis]2[epsis]4 group (42.6  3.7% in the AD cases versus 28.9  1.2% in the only control), whereas nothing was apparent in the [epsis]2[epsis]3 group (39.0  1.4% in the only AD case versus 45.8  4.3% in controls). 

Phrase: "Nevertheless,"

Phrase: "a trend towards the same situation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521798:trend [Temporal Concept]

Phrase: "as"

Phrase: "observed in the [epsis]3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]

Phrase: "[epsis]4 group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "could"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "an increase in the expression of the [epsis]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "in the [epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(42.6  3.7% in the AD cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C0283766:AD 6 [Organic Chemical,Pharmacologic Substance]
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "versus"

Phrase: "28.9  1.2% in the only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205171:Only [Quantitative Concept]
   748   C1720467:Only [Intellectual Product]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "nothing"

Phrase: "was"

Phrase: "apparent in the [epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]

Phrase: "[epsis]3 group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(39.0  1.4% in the only AD case"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0205171:Only [Quantitative Concept]
   742   C0868928:Case [Functional Concept]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]
   742   C1720467:Only [Intellectual Product]

Phrase: "versus"

Phrase: "45.8  4.3% in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.29: Furthermore, a difference in the allelic expression ratio between [epsis]2[epsis]4 and [epsis]3[epsis]4 AD cases was observed, since [epsis]2[epsis]4 patients showed a 1.25-fold increase of the [epsis]4 allele ratio (P = 0.01 with Mann-Whitney test). 

Phrase: "Furthermore,"

Phrase: "a difference in the allelic expression ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between"

Phrase: "[epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "since"

Phrase: "[epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 1.25-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0442805:Increase [Functional Concept]

Phrase: "of the [epsis]4 allele ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "(P = 0.01 with Mann-Whitney test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1708930:Mann-Whitney Test [Intellectual Product]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0392366:test [Intellectual Product]
   748   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.30: Figure 1 Semi-quantitation of the [epsis]4 allele ratio in a control case. 

Phrase: "Figure 1 Semi-quantitation of the [epsis]4 allele ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1709793:Quantitation [Quantitative Concept]

Phrase: "in a control case."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Case [Functional Concept]
   861   C1550141:Control [Substance]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.31: The final [epsis]4 allele ratio calculated from this data was 21.42%. 

Phrase: "The final"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205088:Final [Temporal Concept]
  1000   C1546485:Final [Idea or Concept]

Phrase: "[epsis]4 allele ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "calculated from this data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "21.42%."
Processing 00000000.tx.32: Figure 2 Differential expression of the APOE mRNA for the three heterozygote genotypes in Alzheimer's disease cases and controls. 

Phrase: "Figure 2 Differential expression of the APOE mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1515670:mRNA Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for the three heterozygote genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "in Alzheimer's disease cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.33: The [epsis]2 mRNA percentage was measured in the [epsis]2[epsis]3 population and the [epsis]4 mRNA percentage in the [epsis]3[epsis]4 and [epsis]2[epsis]4 population. 

Phrase: "The [epsis]2 mRNA percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0439165:Percentage [Quantitative Concept]
   804   C1549488:Percentage [Idea or Concept]
   804   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "measured in the [epsis]2"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0444706:Measured [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "[epsis]3 population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "the [epsis]4 mRNA percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0439165:Percentage [Quantitative Concept]
   804   C1549488:Percentage [Idea or Concept]
   804   C1561533:Percentage [Idea or Concept]

Phrase: "in the [epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]
Processing 00000000.tx.34: The average level of expression is indicated by a bold line in each category. 

Phrase: "The average level of expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C3244092:expression level [Idea or Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "indicated by a bold line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205132:Line [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: "in each category."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683312:Category [Intellectual Product]
  1000   C1555713:category [Idea or Concept]
Processing 00000000.tx.35: For each brain sample, RT-PCR and semi-quantitation was repeated three times. 

Phrase: "For each brain sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "semi-quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "three times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.36: DISCUSSION It is important to note that measurement of the ratio of expression of the two alleles in heterozygotes is likely to be a much more robust measurement than the determination of absolute levels of mRNA expression in the same tissue, since the latter will be profoundly affected by post-mortem delay, agonal state and cell population and density. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that measurement of the ratio of expression of the two alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1261161:Ratio measurement [Laboratory Procedure]
   754   C1517025:Expression Measurement [Conceptual Entity]
   738   C0242485:Measurement [Functional Concept]

Phrase: "in heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "a much more robust measurement than the determination of absolute levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0242485:Measurement [Functional Concept]

Phrase: "of mRNA expression in the same tissue,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C1515670:mRNA Expression [Genetic Function]
   795   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0040300:Tissue [Tissue]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   795   C0332285:Of [Spatial Concept]
   795   C0445247:Same [Qualitative Concept]
   795   C1547928:Tissue [Intellectual Product]

Phrase: "since"

Phrase: "the latter"

Phrase: "will"

Phrase: "be"

Phrase: "profoundly"

Phrase: "affected by post-mortem delay,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0004398:postmortem [Diagnostic Procedure]
   806   C0580205:Postmortem [Temporal Concept]
   806   C0848632:post mortem [Finding]
   760   C0205421:Delay [Temporal Concept]
   760   C0392760:Affected [Functional Concept]
   760   C0687676:Post [Temporal Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1704687:Post [Manufactured Object]
   726 E C0001721:Affect [Mental Process]

Phrase: "agonal state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "cell population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "density."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.37: As can be seen in Figure 2, the level of expression of the [epsis]3 allele is consistently higher than that of the [epsis]4 allele in the AD group as well as in the control group. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Figure 2,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "the level of expression of the [epsis]3 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0456949:Level 3 [Intellectual Product]
   757   C3244092:expression level [Idea or Concept]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "consistently higher than that of the [epsis]4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0205250:High [Qualitative Concept]
   706   C1299351:High [Qualitative Concept]
   706   C2700149:HIGH [Intellectual Product]

Phrase: "in the AD group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "as well as in the control group."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0009932:Control Group [Group]
   748   C0205170:Well [Qualitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1550141:Control [Substance]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3146287:Well [Manufactured Object]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.38: These data suggest that there is either differential stability of the different mRNA species, or that there is genetic variability in the expression of the two alleles in disequilibrium with the coding polymorphism. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "either differential stability of the different mRNA species,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1257757:mRNA Stability [Qualitative Concept]
   744   C0205360:Stability [Qualitative Concept]
   744   C2347098:Stability [Qualitative Concept]

Phrase: "or"

Phrase: "that there"

Phrase: "is"

Phrase: "genetic variability in the expression of the two alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C2827666:Variability [Conceptual Entity]
   726   C1868500:Variable expression [Finding]

Phrase: "in disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0281825:Disequilibrium [Finding]
  1000   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with the coding polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.39: However, in addition there was a clear and consistent difference in the [epsis]4 allelic expression ratio between AD cases and controls. 

Phrase: "However,"

Phrase: "in addition there"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]

Phrase: "was"

Phrase: "a clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "consistent difference in the [epsis]4 allelic expression ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "between AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.40: These results are consistent with the notion that part, at least, of the genetic risk of developing AD encoded at the APOE locus relates to the expression of this protein in the brain. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "at least,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "of the genetic risk"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
  1000   C1517512:Genetic Risk [Quantitative Concept]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0035647:Risk [Qualitative Concept]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "of developing AD"

Phrase: "encoded at the APOE locus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0523511:APOE [Laboratory Procedure]
   760   C0679058:encoded [Mental Process]
   760   C1412481:APOE [Gene or Genome]
   760   C1708726:Locus [Gene or Genome]
   760   C2700640:Encoded [Activity]

Phrase: "relates to the expression of this protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1171362:expression protein [Genetic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0163712:Relate [Organic Chemical]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.41: It would seem that heterozygote individuals who express a relatively high proportion of the [epsis]4 allele are at greater risk for developing disease than those expressing a relatively low proportion. 

Phrase: "It"

Phrase: "would"

Phrase: "seem"

Phrase: "that heterozygote individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "who"

Phrase: "express"

Phrase: "a relatively high proportion of the [epsis]4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709707:Proportion [Quantitative Concept]

Phrase: "are at greater risk"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0035647:Risk [Qualitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1551058:Are [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "for developing disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "than those"

Phrase: "expressing"

Phrase: "a relatively low proportion."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   755 E C0205351:Proportional [Qualitative Concept]
Processing 00000000.tx.42: The observation that the different alleles of APOE are not equally expressed may be of importance in the formulation of hypotheses relating to the role of APOE in the pathogenesis of AD in general. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the different alleles of APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]

Phrase: "are"

Phrase: "not equally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "expressed"

Phrase: "may"

Phrase: "be of importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2987476:Be [Conceptual Entity]

Phrase: "in the formulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524527:Formulation [Research Activity]

Phrase: "of hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512571:Hypothesis [Idea or Concept]

Phrase: "relating to the role of APOE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0035820:Role [Social Behavior]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1705810:Role [Conceptual Entity]
   719   C0163712:Relate [Organic Chemical]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of AD"

Phrase: "in general."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]
Processing 00000000.tx.43: At present, there is much speculation and experimentation designed to determine the nature of the role of the different alleles of APOE in the pathogenesis of AD. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "there"

Phrase: "is"

Phrase: "much speculation"

Phrase: "and"

Phrase: "experimentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678323:experimentation [Research Activity]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the nature of the role of the different alleles of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0349590:Nature [Idea or Concept]
   738   C1262865:Nature [Functional Concept]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of AD."
Processing 00000000.tx.44: As previously suggested, the E4 isoform may facilitate (12) or not limit (13) the amyloid substance deposition. 

Phrase: "As"

Phrase: "previously"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: ","

Phrase: "the E4 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "facilitate"

Phrase: "(12"

Phrase: ")"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "(13"

Phrase: ")"

Phrase: "the amyloid substance deposition."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0011560:Amyloid deposition [Pathologic Function]
   913   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]
   734   C0002716:Amyloid Substance [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0002723:amyloid substance [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.45: This isoform would not protect against oxidative stress, conversely to the E2 isoform (14). 

Phrase: "This isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "protect against oxidative stress,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "conversely to the E2 isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   760   C3539520:E2 [Gene or Genome]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.46: Finally, it has been suggested that the E2 and E3 isoforms may prevent the aggregation of Tau protein, while the E4 isoform may not prevent the paired helical filament formation (15). 

Phrase: "Finally,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "E3 isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the aggregation of Tau protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "while"

Phrase: "the E4 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the paired helical filament formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.47: However, these hypotheses are based on the premise that the APOE allele isoforms are equally expressed and present at similar concentrations in the brain. 

Phrase: "However,"

Phrase: "these hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512571:Hypothesis [Idea or Concept]

Phrase: "are"

Phrase: "based on the premise"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "the APOE allele isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "equally"

Phrase: "expressed"

Phrase: "and"

Phrase: "present at similar concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.48: These isoform-specific differences could be enhanced by a different representation of each isoform in an individual. 

Phrase: "These isoform-specific differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "enhanced by a different representation of each isoform"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   744   C1514861:Representation [Conceptual Entity]
   744   C1705242:Different [Qualitative Concept]
   744   C1882932:Representation [Activity]
   744   C2349975:Enhanced [Activity]

Phrase: "in an individual."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]
Processing 00000000.tx.49: To date, it seems difficult to link APOE mRNA and apoE protein levels. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "it"

Phrase: "seems"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "APOE mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "apoE protein levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.50: Several studies had explored this issue reporting contradictory findings in brain (10,16), cerebrospinal fluid (17,18) and plasma (19). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "explored"

Phrase: "this issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "contradictory findings in brain"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   819   C0576471:brain findings [Finding]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "(10,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "(17,"

Phrase: "18"

Phrase: ")"

Phrase: "and"

Phrase: "plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.51: But even if the apoE level was tested according to the APOE genotype, none of the previous studies have been able to determine the relative ratio between the different isoforms and thus our results are not comparable with them. 

Phrase: "But"

Phrase: "even"

Phrase: "if"

Phrase: "the apoE level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "tested according to the APOE genotype,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017431:Genotype [Organism Attribute]
   753   C0392366:tested [Intellectual Product]
   753   C0523511:APOE [Laboratory Procedure]
   753   C0680240:according [Social Behavior]
   753   C1412481:APOE [Gene or Genome]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]

Phrase: "none of the previous studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205156:Previous [Temporal Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "determine"

Phrase: "the relative ratio between the different isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1264683:Relative ratio [Quantitative Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "thus"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "not comparable with them."
Processing 00000000.tx.52: The development of isoform-specific monoclonal antibodies would help to determine whether the variation that is observed in our population is also present at the protein level (20). 

Phrase: "The development of isoform-specific monoclonal antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "would"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "observed in our population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]
   770   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "present at the protein level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0150312:Present [Quantitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.53: There are two major findings in our work. 

Phrase: "There"

Phrase: "are"

Phrase: "two major findings in our work."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]
Processing 00000000.tx.54: First, that the expression of the [epsis]3 allele is consistently higher than the expression of the [epsis]4 allele. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "that"

Phrase: "the expression of the [epsis]3 allele"

Phrase: "is"

Phrase: "consistently higher than the expression of the [epsis]4 allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   704   C0205250:High [Qualitative Concept]
   704   C1299351:High [Qualitative Concept]
   704   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.55: Second, that the expression of the [epsis]4 allele beyond a certain level seems to greatly influence the vulnerability of an individual to Alzheimer's disease. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "that"

Phrase: "the expression of the [epsis]4 allele"

Phrase: "beyond a certain level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "seems"

Phrase: "to greatly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the vulnerability of an individual"

Phrase: "to Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.56: It is interesting to note that APOE is up-regulated as a consequence of an insult. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "up-regulated as a consequence of an insult."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0686907:Consequence of [Functional Concept]
           Consequence
   744   C0547043:Up [Spatial Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1282911:Up [Spatial Concept]
Processing 00000000.tx.57: Poirier et al. showed an increase in the level of expression of APOE mRNA in rat after lesioning of the cerebral cortex (6). 

Phrase: "Poirier et al."

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increase in the level of expression of APOE mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "after lesioning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0221198:Lesion [Finding]
   966   C1546698:Lesion [Intellectual Product]

Phrase: "of the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.58: Similarly, Diedrich et al. showed that APOE mRNA was increased in AD brains (5). 

Phrase: "Similarly,"

Phrase: "Diedrich et al."

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that APOE mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "increased in AD brains"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.59: Together these results support an event, which may lead to an increase of the APOE mRNA and, in parallel, a distortion of the allelic expression. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "which"

Phrase: "may"

Phrase: "lead to an increase of the APOE mRNA"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442805:Increase [Functional Concept]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1412481:APOE [Gene or Genome]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: ","

Phrase: "in parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "a distortion of the allelic expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332482:Distortion [Anatomical Abnormality]
   753   C2919017:Distortion [Qualitative Concept]
Processing 00000000.tx.60: The distortion of the allelic expression may be specific to brain, and possibly restricted to certain areas (21). 

Phrase: "The distortion of the allelic expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332482:Distortion [Anatomical Abnormality]
   753   C2919017:Distortion [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "specific to brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "restricted to certain areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205146:areas [Spatial Concept]
   770   C0443288:Restricted [Functional Concept]
   737 E C0017446:Area [Geographic Area]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.61: This suggests a neural genetic susceptibility for AD associated with the APOE gene. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a neural genetic susceptibility for AD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0314657:Genetic Susceptibility [Organism Attribute]
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C0314603:Genetic [Functional Concept]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "associated with the APOE gene."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1412481:APOE gene [Gene or Genome]
           APOE
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   760   C0523511:APOE [Laboratory Procedure]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.62: Interestingly, Templeton reached a similar conclusion using a cladistic analysis of our previously reported genetic data (4). 

Phrase: "Interestingly,"

Phrase: "Templeton"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a similar conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusion [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cladistic analysis of our previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "genetic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.63: Using haplotype data from markers surrounding the APOE locus, including the APOE polymorphism, Templeton showed that the coding polymorphism in the APOE gene was not sufficient to explain the increased risk for AD (22). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "haplotype data from markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the APOE locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the APOE polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "Templeton"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the coding polymorphism in the APOE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0678951:gene polymorphism [Genetic Function]
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "the increased risk for AD (22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035647:Risk [Qualitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]

Phrase: ")."
Processing 00000000.tx.64: Our data suggest that the influence of non-coding polymorphism on ApoE expression may supply the rest of the answer. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the influence of non-coding polymorphism"

Phrase: "on ApoE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "supply"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0243163:supply [Idea or Concept]
  1000   C0699914:supply [Quantitative Concept]
  1000   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
  1000   C1561604:supply [Functional Concept]
  1000   C1875802:SUPPLY [Medical Device]
  1000   C1999230:Supply [Activity]

Phrase: "the rest of the answer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035253:Rest [Daily or Recreational Activity]
   760   C1622890:ResT [Molecular Function]
Processing 00000000.tx.65: MATERIALS AND METHODS RNA extraction Fourteen late-onset AD cases of Caucasian origin with a mean age of 74.1  11.8 years (five male and nine female) and 12 controls with a mean age of 83.0  10.6 years (five male and seven female) were selected as a function of their APOE genotype (23). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RNA extraction Fourteen late-onset AD cases of Caucasian origin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   738   C0868928:Cases [Functional Concept]
   738   C1533148:Cases [Quantitative Concept]
   704 E C1706255:CASE [Medical Device]
   704 E C1706256:Case [Conceptual Entity]

Phrase: "with a mean age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "of 74.1  11.8 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(five male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "nine female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "12 controls with a mean age of 83.0  10.6 years"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   703   C0243148:control [Qualitative Concept]
   703   C1550141:Control [Substance]
   703   C1882979:Control [Conceptual Entity]
   703   C2587213:Control [Functional Concept]
   703   C3274648:Control [Qualitative Concept]

Phrase: "(five male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "seven female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "selected as a function of their APOE genotype"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017431:Genotype [Organism Attribute]
   744   C0031843:function [Physiologic Function]
   744   C0523511:APOE [Laboratory Procedure]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1412481:APOE [Gene or Genome]
   744   C1705273:Function [Intellectual Product]
   711   C1707391:Select [Activity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.66: The mean age at sampling was 75.6  8.8 years for the AD cases genotyped [epsis]3[epsis]4 and 77.6  11.0 years for the controls genotyped [epsis]3[epsis]4. 

Phrase: "The mean age at sampling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "75.6  8.8 years for the AD cases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0439234:years [Temporal Concept]
   708 E C0439508:/year [Temporal Concept]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "[epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "77.6  11.0 years for the controls"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439234:years [Temporal Concept]
   711 E C0439508:/year [Temporal Concept]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "[epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.67: Diagnoses were confirmed by neuropathological examination. 

Phrase: "Diagnoses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0011900:Diagnoses [Finding]
   966 E C1704338:diagnosis [Qualitative Concept]
   966 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "confirmed by neuropathological examination."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.68: Total RNA extraction was performed from frontal lobe samples as described by Gilmour et al. 

Phrase: "Total RNA extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]

Phrase: "was"

Phrase: "performed from frontal lobe samples"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0016733:frontal lobe [Body Part, Organ, or Organ Component]
   806   C1268977:Frontal lobe [Body Part, Organ, or Organ Component]
   760   C0205123:Frontal [Spatial Concept]
   760   C0796494:lobe [Body Part, Organ, or Organ Component]
   760   C0884358:Performed [Functional Concept]
   760   C1428707:Lobe [Gene or Genome]
   760   C3539671:Lobe [Gene or Genome]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Gilmour et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.69: (24) and then digested by DNase (Eurogentec). 

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested by DNase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0868946:digested [Physiologic Function]

Phrase: "(Eurogentec"

Phrase: ")."
Processing 00000000.tx.70: No DNA contamination was observed after DNase digestion as detected by PCR of the digested product. 

Phrase: "No DNA contamination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]

Phrase: "was"

Phrase: "observed after DNase digestion"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0012238:Digestion [Organism Function]
   770   C1441672:Observed [Functional Concept]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "as"

Phrase: "detected by PCR of the digested product."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0442726:Detected [Finding]
   748   C0677874:pCR [Finding]
   748   C0868946:digested [Physiologic Function]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.71: RT-PCR amplification of APOE mRNAs The RT reaction was performed for 1 h 30 min at 37C, using the F4 primer 5[prime]-ACAGAATTCGCCCCGGCCTGGTA-3[prime] at 50 pmol and 1 [mu]g of total RNA as template for the M-MLV reverse transcriptase following the conditions described by the supplier (Gibco/BRL). 

Phrase: "RT-PCR amplification of APOE mRNAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "The RT reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "performed for 1 h 30 min"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   783   C0700308:h 1 [Element, Ion, or Isotope]
   783   C1301862:Min 1 [Temporal Concept]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C0702093:/min [Temporal Concept]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at 37C,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the F4 primer 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-ACAGAATTCGCCCCGGCCTGGTA-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "at 50 pmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "[mu]g of total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1532982:mU/g [Quantitative Concept]
   760   C0439267:g% [Quantitative Concept]

Phrase: "as template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]

Phrase: "for the"

Phrase: "M-"

Phrase: "MLV reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1555029:Reverse [Idea or Concept]
   827   C2257077:transcriptase [Genetic Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "described by the supplier"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0470689:Supplier [Health Care Related Organization]
   770   C0470690:supplier [Health Care Related Organization]
   770   C1552738:described [Idea or Concept]

Phrase: "(Gibco/BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.72: The PCR step was carried out with the F6 primer 5[prime]-TAAGCTTGGCACGGCTGTCCAAGGA-3[prime] at 50 pmol in a final volume of 10 [mu]l, for 30 cycles (1 min at 94C, 1 min at 58C and 1 min at 72C each cycle) to remain in the linear range of the reaction. 

Phrase: "The PCR step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with the F6 primer 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TAAGCTTGGCACGGCTGTCCAAGGA-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "at 50 pmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 10"

Phrase: "[mu]l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439342:mU/L [Quantitative Concept]

Phrase: "for 30 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "(1 min at 94C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "1 min at 58C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "1 min at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "each cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remain in the linear range of the reaction."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205132:Linear [Spatial Concept]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
Processing 00000000.tx.73: Briefly, PCR was performed in a total volume of 25 [mu]l containing 1.25 U Taq DNA polymerase, 0.2 mM of each dNTP, 4 mM of DTT, 0.1 mM of MgCl2, 0.04% of Triton X-100, 10% (v/v) of glycerol using the whole RT reaction as template. 

Phrase: "Briefly,"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed in a total volume of 25"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0449468:Total Volume [Quantitative Concept]
           *Volume
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C1690016:% volume [Qualitative Concept]
   748   C1705102:Volume [Intellectual Product]
   748   C2700258:Volume [Laboratory Procedure]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "[mu]l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439342:mU/L [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.25 U Taq DNA polymerase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
   861   C2257065:Taq DNA polymerase [Genetic Function]
   827   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "0.2 mM of each dNTP,"

Phrase: "4 mM of DTT,"

Phrase: "0.1 mM of MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1418486:MM-1 [Gene or Genome]

Phrase: "0.04% of Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   753   C0242759:Triton [Geographic Area]

Phrase: "10%"

Phrase: "(v/v) of glycerol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0560268:%V/V [Quantitative Concept]
   833   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the whole RT reaction as template."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.74: Electrophoresis RT-PCR DNA was then digested by 12 U CfoI endonuclease (Promega), DNA fragments were resolved on an 8% polyacrylamide gel (acrylamide:bisacrylamide 19:1), over 4 h at 12 V/cm. 

Phrase: "Electrophoresis RT-PCR DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested by 12 U CfoI endonuclease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0115851:CfoI endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0868946:digested [Physiologic Function]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "DNA fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "resolved on an 8% polyacrylamide gel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "(acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "bisacrylamide 19"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "over 4 h at 12 V/cm."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.75: A range from 6 to 0.2 [mu]l of the RT-PCR product was loaded. 

Phrase: "A range from 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "to 0.2"

Phrase: "[mu]l of the RT-PCR product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0439342:mU/L [Quantitative Concept]

Phrase: "was"

Phrase: "loaded."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.76: Silver staining The gel was fixed over 90 min in 10% (v/v) ethanol, 0.5% (v/v) acetic acid. 

Phrase: "Silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "fixed over 90 min"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0231441:Fixed [Finding]
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in 10%"

Phrase: "(v/v) ethanol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001962:Ethanol [Organic Chemical]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(v/v) acetic acid."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0000985:Acetic acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   756 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.77: After two washings with deionised water, the gel was placed in silver nitrate solution (1 mg/ml) for 25 min. 

Phrase: "After two washings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Washing [Activity]

Phrase: "with deionised water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "the gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "placed in silver nitrate solution"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   806   C0037129:Silver Nitrate [Inorganic Chemical,Pharmacologic Substance]
   806   C1161347:silver nitrate [Pharmacologic Substance]
   806   C1321600:Silver nitrate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   760   C0028125:Nitrate [Chemical Viewed Structurally]
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C0699857:Nitrate [Inorganic Chemical]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "(1 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) for 25 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0439445:mL/min [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.78: The gel was then washed twice with deionised water. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with deionised water."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.79: The DNA polymorphism fragments were stained for 30 min in 0.037 % formaldehyde (v/v), hydroxyde nitrate (15 mg/ml). 

Phrase: "The DNA polymorphism fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "stained for 30 min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in 0.037 % formaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(v/v), hydroxyde nitrate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0028125:Nitrate [Chemical Viewed Structurally]
   812   C0699857:Nitrate [Inorganic Chemical]
   712 E C1328815:nitration [Phenomenon or Process]

Phrase: "(15 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.80: Finally, the reaction was stopped in a sodium carbonate solution (15 mg/ml). 

Phrase: "Finally,"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped in a sodium carbonate solution"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]
   753   C0007026:Carbonate [Inorganic Chemical]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1272691:stopped [Qualitative Concept]
   719 E C1947925:Stop [Activity]
   719 E C2746065:Stop [Temporal Concept]

Phrase: "(15 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.81: The developer and silver nitrate solutions were prepared extemporaneously. 

Phrase: "The developer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2363670:developer [Medical Device]

Phrase: "and"

Phrase: "silver nitrate solutions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]
   734   C0037129:Silver Nitrate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161347:silver nitrate [Pharmacologic Substance]
   734   C1321600:Silver nitrate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "extemporaneously."
Processing 00000000.tx.82: The gel was digitalised on a Sharp JX-325 high resolution colour scanner, and the fragment intensity was measured using the Image Master Software (Pharmacia) with appropriate background subtract. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "digitalised on a Sharp JX-325 high resolution colour scanner,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0493060:SCANNER, COLOR [Medical Device]
   760   C1719039:High resolution [Laboratory Procedure]
   739   C0009393:Color [Natural Phenomenon or Process]
   739   C0183115:scanner [Medical Device]
   739   C0205250:High [Qualitative Concept]
   739   C0554831:Digitalised [Therapeutic or Preventive Procedure]
   739   C1299351:High [Qualitative Concept]
   739   C1444775:Sharp [Finding]
   739   C1514893:Resolution [Idea or Concept]
   739   C1539835:SHARP [Gene or Genome]
   739   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   739   C1705245:Color [Pharmacologic Substance]
   739   C1706463:Resolution [Quantitative Concept]
   739   C1710020:Scanner [Medical Device]
   739   C2699488:Resolution [Conceptual Entity]
   739   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "the fragment intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Image Master Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "with appropriate background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "subtract."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1719767:Subtract [Intellectual Product]
  1000   C2348589:Subtract [Phenomenon or Process]
Processing 00000000.tx.83: Allele quantitation The percentage of the [epsis]4 allele was calculated with the equation below as described in ref. 

Phrase: "Allele quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "The percentage of the [epsis]4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439165:Percentage [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "calculated with the equation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444686:Calculated [Functional Concept]
   770   C0552449:Equation [Conceptual Entity]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]

Phrase: "below"

Phrase: "as"

Phrase: "described in ref."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1425988:REF [Gene or Genome]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.84: 11: No[epsis]4 mRNA and No[epsis]3 mRNA were the initial number of the [epsis]3 and [epsis]4 mRNAs. 

Phrase: "11"

Phrase: ":"

Phrase: "No[epsis]4 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "No[epsis]3 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "the initial number of the [epsis]3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "and ["

Phrase: "epsis]4 mRNAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.85: [alpha][prime][epsis]4 mRNA and [alpha][prime][epsis]2 or [epsis]3 mRNA were the coefficients allowing silver staining, and the phenomenon of saturation due to this staining, to be integrated and normalised. 

Phrase: "[alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439095:Alpha [Intellectual Product]
  1000   C2003941:Alpha [Intellectual Product]
  1000   C2350010:Alpha [Qualitative Concept]

Phrase: "]"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "[epsis]4 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and ["

Phrase: "alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439095:Alpha [Intellectual Product]
  1000   C2003941:Alpha [Intellectual Product]
  1000   C2350010:Alpha [Qualitative Concept]

Phrase: "]"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "[epsis]2 or [epsis]3 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "the coefficients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707429:*Coefficient [Quantitative Concept]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "silver staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "the phenomenon of saturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "due to this staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "integrated"

Phrase: "and"

Phrase: "normalised."
Processing 00000000.tx.86: A is a coefficient of proportionality, correcting for the length difference between each restriction fragments. 

Phrase: "A"

Phrase: "is"

Phrase: "a coefficient of proportionality,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707429:*Coefficient [Quantitative Concept]

Phrase: "correcting for the length difference"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1444754:Length [Quantitative Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   760   C1706316:LENGTH [Research Activity]
   726   C2349182:Correct [Qualitative Concept]

Phrase: "between each restriction fragments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0332255:fragments [Functional Concept]
   861   C0443288:Restriction [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.87: After digestion by CfoI, the [epsis]3, [epsis]2 and [epsis]4 alleles can be characterised by 91, 83 and 72 bp fragments, respectively. 

Phrase: "After digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "by CfoI,"

Phrase: "the [epsis]3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "epsis]4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "characterised by 91,"

Phrase: "83"

Phrase: "and"

Phrase: "72 bp fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.88: The A coefficient is therefore calculated as A = 91/72 for [epsis]3[epsis]4 individuals, A = 83/72 for [epsis]2[epsis]4 individuals and A = 91/83 for the [epsis]2[epsis]3 population. 

Phrase: "The"

Phrase: "A coefficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707429:*Coefficient [Quantitative Concept]

Phrase: "is"

Phrase: "therefore"

Phrase: "calculated as A = 91/72"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]

Phrase: "for"

Phrase: "[epsis]3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "A = 83/72 for"

Phrase: "[epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]4 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "and"

Phrase: "A = 91/83 for the [epsis]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0604154:A-91 [Organic Chemical,Pharmacologic Substance]
   767   C1825406:A-2 [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[epsis]3 population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]
Processing 00000000.tx.89: Because both [epsis]2 and [epsis]3 alleles give a restriction length fragment at 91 bp, AOD[epsis]2 mRNA + OD[epsis]3 mRNA = OD91 bp. 

Phrase: "Because"

Phrase: "both"

Phrase: "[epsis]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "epsis]3 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a restriction length fragment at 91 bp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "AOD[epsis]2 mRNA + OD[epsis]3 mRNA = OD91 bp."
Processing 00000000.tx.90: The initial [epsis]2 allele percentage in the [epsis]2[epsis]3 population was calculated as: Details of the calculations and modelling of the method are described in ref. 

Phrase: "The initial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205265:Initial [Temporal Concept]
  1000   C1279901:Initial [Qualitative Concept]
  1000   C1555582:Initial [Idea or Concept]
  1000   C1705685:INITIAL [Functional Concept]

Phrase: "[epsis]2 allele percentage in the [epsis]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0439165:Percentage [Quantitative Concept]
   739   C1549488:Percentage [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]

Phrase: "[epsis]3 population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: ":"

Phrase: "Details of the calculations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1522508:Details [Qualitative Concept]
   737 E C1561567:detail [Functional Concept]

Phrase: "and"

Phrase: "modelling of the method"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: "are"

Phrase: "described in ref."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1425988:REF [Gene or Genome]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.91: 11. 

Phrase: "11."
Processing 00000000.tx.92: We tested the viability of this approach on the APOE alleles by using genomic DNA as template for different parameters such as initial concentrations of DNA template or initial percentage of an allele compared with another (11). 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the viability of this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443348:viability [Qualitative Concept]

Phrase: "on the APOE alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "genomic DNA as template"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   819   C0678713:DNA template [Genetic Function]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0017428:Genomic [Gene or Genome]
   770   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "for different parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "such as initial concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827826:Initial Concentration [Quantitative Concept]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of DNA template"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0678713:DNA template [Genetic Function]
   861   C0728990:TEMPLATE [Medical Device]
   861   C1514575:Template [Conceptual Entity]
   861   C1705542:Template [Idea or Concept]

Phrase: "or"

Phrase: "initial percentage of an allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "compared with another"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.93: Linear regressions (necessary to perform ratio percentage) and Mann-Whitney U-test were performed using SAS software release 6.04 (SAS Institute Inc., Cary, NC, USA). 

Phrase: "Linear regressions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023733:Regressions, Linear [Quantitative Concept]
   983 E C2346679:Linear Regression [Intellectual Product]
   861   C0684320:regressions [Pathologic Function]
   861   C0684321:regressions [Mental Process]

Phrase: "(necessary to"

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "ratio percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439165:Percentage [Quantitative Concept]
   861   C1549488:Percentage [Idea or Concept]
   861   C1561533:Percentage [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Mann-Whitney U-test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242927:Mann-Whitney U Test [Quantitative Concept]
   923   C1708930:Mann-Whitney Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SAS software release 6.04"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   875   C1822613:SAS-6 [Gene or Genome]
   804   C0030685:Release [Health Care Activity]
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0605290:SAS [Organic Chemical]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1426104:SAS [Gene or Genome]
   804   C1823519:SAS [Gene or Genome]
   804   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(SAS Institute Inc.,"

Phrase: "Cary,"

Phrase: "NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.94: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. 

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.96: George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D. 

Phrase: "George-Hyslop,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Joo,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rosi,"

Phrase: "B.L., Gusella,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Crapper-MacLachlan,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Alberts,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crain,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.97: (1993) Association of apolipoprotein E allele [epsis]4 with late-onset familial and sporadic Alzheimer's disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Association of apolipoprotein E allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "[epsis]4 with late-onset familial"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0015576:familial [Family Group]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205087:Late [Temporal Concept]
   748   C0241888:Familial [Functional Concept]
   748   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.98: Neurology, 43, 1467-1472. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "43,"

Phrase: "1467-1472."
Processing 00000000.tx.99: MEDLINE Abstract 2. 

Phrase: "MEDLINE Abstract 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.100: Van Duijn, C.M., De Kniff, P., Wehnert, A., De Voecht, J., Bronzova, J.B., Havekes, L.M., Hofman, A. and Van Broeckhoven, C. 

Phrase: "Van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "De Kniff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "De Voecht,"

Phrase: "J.,"

Phrase: "Bronzova,"

Phrase: "J.B.,"

Phrase: "Havekes,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.101: (1995) Reduced survival of patients with early-onset Alzheimer's disease that carry the Apolipoprotein [Egr]2 allele. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Reduced survival of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "with early-onset Alzheimer's disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the Apolipoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[Egr]2 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.102: Ann. 

Phrase: "Ann."
Processing 00000000.tx.103: Neurol., 37, 605-610. 

Phrase: "Neurol.,"

Phrase: "37,"

Phrase: "605-610."
Processing 00000000.tx.104: MEDLINE Abstract 3. 

Phrase: "MEDLINE Abstract 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.105: Prez-Tur, J., Campion, D., Martinez, M., Brice, A., Tardieu, S., Hannequin, D., Agid, Y., Delacourte, A., Clerget-Darpoux, F., Chartier-Harlin, M.-C. and the French Alzheimer's disease collaborative group (1995) Evidence for apolipoprotein E [epsis]4 association in early-onset Alzheimer's patients with late-onset relatives. 

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Martinez,"

Phrase: "M."

Phrase: ","

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Tardieu,"

Phrase: "S."

Phrase: ","

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Delacourte,"

Phrase: "A.,"

Phrase: "Clerget-Darpoux,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Chartier-Harlin,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "the French Alzheimer's disease collaborative group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: "(1995"

Phrase: ")"

Phrase: "Evidence for apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "[epsis]4 association in early-onset Alzheimer's patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "with late-onset relatives."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0080103:Relatives [Family Group]
   793 E C0205345:Relative [Qualitative Concept]
   793 E C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.106: Am. 

Phrase: "Am."
Processing 00000000.tx.107: J. 

Phrase: "J."
Processing 00000000.tx.108: Med. 

Phrase: "Med."
Processing 00000000.tx.109: Genet., 60, 550-553. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "60,"

Phrase: "550-553."
Processing 00000000.tx.110: MEDLINE Abstract 4. 

Phrase: "MEDLINE Abstract 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.111: Chartier-Harlin, M.-C., Parfitt, M., Legrain, S., Prez-Tur, J., Brousseau, T., Evans, A., Berr, C., Vidal, O., Roques, P., Gourlet, V., Fruchart, J.C., Delacourte, A., Rossor, M. and Amouyel, P. 

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Parfitt,"

Phrase: "M."

Phrase: ","

Phrase: "Legrain,"

Phrase: "S."

Phrase: ","

Phrase: "Prez-Tur,"

Phrase: "J.,"

Phrase: "Brousseau,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Evans,"

Phrase: "A.,"

Phrase: "Berr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gourlet,"

Phrase: "V.,"

Phrase: "Fruchart,"

Phrase: "J.C., Delacourte,"

Phrase: "A.,"

Phrase: "Rossor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.112: (1994) Apolipoprotein E [epsis]4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis]4 allele as a major risk factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]

Phrase: "for sporadic early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "forms of Alzheimer's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "analysis of the 19q13.2 chromosomal region."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0853259:chromosomal analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   738 E C0200867:Chromosome analysis [Laboratory Procedure]
Processing 00000000.tx.113: Hum. 

Phrase: "Hum."
Processing 00000000.tx.114: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.115: Genet., 3, 569-574. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "569-574."
Processing 00000000.tx.116: MEDLINE Abstract 5. 

Phrase: "MEDLINE Abstract 5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.117: Diedrich, J.F., Minnigan, H., Carp, R.I., Whitaker, J.N., Race, R., Frey, W.,II and Haase, A.T. 

Phrase: "Diedrich,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Minnigan,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Carp,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007284:carp [Fish]
  1000   C0328038:Carp [Fish]
  1000   C0677526:Carp [Food]

Phrase: "R.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Whitaker,"

Phrase: "J.N., Race,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034510:Race [Population Group]
   827   C1706779:RACE [Gene or Genome]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frey,"

Phrase: "W.,II"

Phrase: "and"

Phrase: "Haase,"

Phrase: "A.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]
Processing 00000000.tx.118: (1991) Neuropathological changes in Scrapie and Alzheimer's disease are associated with increased expression of Apolipoprotein E and Cathepsin D in astrocytes. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuropathological changes in Scrapie"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "associated with increased expression of Apolipoprotein E"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "Cathepsin D in astrocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.119: J. 

Phrase: "J."
Processing 00000000.tx.120: Virol., 65, 4759-4768. 

Phrase: "Virol.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "4759-4768."
Processing 00000000.tx.121: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.122: Poirier, J., Hess, M., May, P.C. and Finch, C.E. 

Phrase: "Poirier,"

Phrase: "J.,"

Phrase: "Hess,"

Phrase: "M."

Phrase: ","

Phrase: "May,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.123: (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Astrocytic apolipoprotein E mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GFAP mRNA in hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "after entorhinal cortex lesioning."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0221198:Lesion [Finding]
   793   C1546698:Lesion [Intellectual Product]
   734   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   734   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
Processing 00000000.tx.124: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.125: Brain Res., 11, 97-106. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "11,"

Phrase: "97-106."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.126: MEDLINE Abstract 7. 

Phrase: "MEDLINE Abstract 7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.127: Malhey, R.W. 

Phrase: "Malhey,"

Phrase: "R.W."
Processing 00000000.tx.128: (1988) Apolipoprotrein E: cholesterol transport protein with expanding role in cell biology. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Apolipoprotrein E"

Phrase: ":"

Phrase: "cholesterol transport protein with expanding role in cell biology."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0007292:Transport protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159709:cholesterol transport [Cell Function]
   762 E C0599895:protein transport [Cell Function]
   762 E C1159772:Protein Transport [Cell Function]
   742   C0005528:Transport, NOS [Cell Function]
           Biologic Transport
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1317949:Transport [Manufactured Object]
   742   C3495449:transport [Medical Device]
Processing 00000000.tx.129: Science, 240, 622-630. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "240,"

Phrase: "622-630."
Processing 00000000.tx.130: 8. 

Phrase: "8."
Processing 00000000.tx.131: Leblanc, A.C. and Poduslo, J.F. 

Phrase: "Leblanc,"

Phrase: "A.C."

Phrase: "and"

Phrase: "Poduslo,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.132: (1990) Regulation of Apolipoprotein E gene expression after injury of the rat sciatic nerve. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Regulation of Apolipoprotein E gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "after injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "of the rat sciatic nerve."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0036394:Sciatic Nerve [Body Part, Organ, or Organ Component]
   901   C1278851:Sciatic nerve [Body Part, Organ, or Organ Component]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.133: J. 

Phrase: "J."
Processing 00000000.tx.134: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.135: Res., 25, 162-171. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "25,"

Phrase: "162-171."
Processing 00000000.tx.136: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.137: Guillaume, D., Dea, D., Davignon, J. and Poirier, J. 

Phrase: "Guillaume,"

Phrase: "D."

Phrase: ","

Phrase: "Dea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512006:DEA [Health Care Related Organization]

Phrase: "D."

Phrase: ","

Phrase: "Davignon,"

Phrase: "J."

Phrase: "and"

Phrase: "Poirier,"

Phrase: "J."
Processing 00000000.tx.138: (1995) Low-density lipoprotein pathways in the central nervous system and Apolipoprotein E isoform-specific differences. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Low-density lipoprotein pathways in the central nervous system"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1704259:Pathways [Molecular Function]
   742   C1705987:Pathways [Conceptual Entity]
   700   C0027792:Neural Pathways [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Apolipoprotein E isoform-specific differences."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   771   C1705241:*Difference [Quantitative Concept]
   771   C1705242:Difference [Qualitative Concept]
   721 E C0443199:Differential [Qualitative Concept]
   717   C0443526:Apolipoprotein E isoform [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
Processing 00000000.tx.139: In Iqbal, Mortimer, Winblad and Wisniewski (eds) Research Advances in Alzheimer's Disease and Related Disorders. 

Phrase: "In Iqbal,"

Phrase: "Mortimer,"

Phrase: "Winblad"

Phrase: "and"

Phrase: "Wisniewski"

Phrase: "(eds) Research Advances in Alzheimer's Disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]

Phrase: "and"

Phrase: "Related Disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.140: John Wiley and Son, pp. 

Phrase: "John Wiley"

Phrase: "and"

Phrase: "Son,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037683:Son [Family Group]

Phrase: "pp."
Processing 00000000.tx.141: 386-395. 

Phrase: "386-395."
Processing 00000000.tx.142: 10. 

Phrase: "10."
Processing 00000000.tx.143: Bertrand, P., Poirier, J., Oda, T., Finch, C.E. and Pasinetti, G.M. 

Phrase: "Bertrand,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Poirier,"

Phrase: "J.,"

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Pasinetti,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.144: (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E apolipoprotein J (clusterin) in Alzheimer disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Association of apolipoprotein E genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0441889:Levels [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of apolipoprotein E apolipoprotein J"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   902   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   902   C2609437:Apolipoprotein J [Laboratory Procedure]

Phrase: "(clusterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055966:Clusterin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:CLUSTERIN [Gene or Genome]

Phrase: ")"

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.145: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.146: Brain Res., 33, 174-178. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "33,"

Phrase: "174-178."
Processing 00000000.tx.147: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.148: Lambert, J.-C., Prez-Tur, J., Amouyel, P., Delacourte, A. and Chartier-Harlin, M.-C. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.-C., Prez-Tur,"

Phrase: "J.,"

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Delacourte,"

Phrase: "A."

Phrase: "and"

Phrase: "Chartier-Harlin,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.149: (1997) Overcoming and normalisation of the signal saturation due to silver staining: a way to quantify allele specific RT-PCR products. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Overcoming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2983310:Overcome [Activity]

Phrase: "and"

Phrase: "normalisation of the signal saturation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882115:Normalization [Research Activity]

Phrase: "due to silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: ":"

Phrase: "a way to"

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "allele specific RT-PCR products."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.150: Nucleic Acids Res., submitted. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "submitted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]
Processing 00000000.tx.151: 12. 

Phrase: "12."
Processing 00000000.tx.152: Strittmatter, W.J, Weisgraber, K.H., Huang, D.Y., Dong, L.-M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M, Goldgaber, D. and Roses, A.D. 

Phrase: "Strittmatter,"

Phrase: "W.J,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Salvesen,"

Phrase: "G.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.153: (1993) Binding of human apolipoprotein E to synthetic amyloid [beta] peptide: isoform-specific effects and implications for late-onset Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Binding of human apolipoprotein E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2247768:apolipoprotein binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to synthetic amyloid [beta] peptide"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   923   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   902   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: ":"

Phrase: "isoform-specific effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "implications for late-onset Alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.154: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.155: Natl. 

Phrase: "Natl."
Processing 00000000.tx.156: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.157: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.158: USA, 90, 8098-8102. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "8098-8102."
Processing 00000000.tx.159: MEDLINE Abstract 13. 

Phrase: "MEDLINE Abstract 13."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.160: Evans, K., Berger, E.P., Cho, C.G., Weisgraber, K.H. and Lansburry, P.T. 

Phrase: "Evans,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Berger,"

Phrase: "E.P.,"

Phrase: "Cho,"

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lansburry,"

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.161: (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implication for the pathogenesis and treatment of Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a kinetic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0022702:kinetic [Natural Phenomenon or Process]
   944 E C0026597:Motion [Natural Phenomenon or Process]
   944 E C0687704:Motions [Functional Concept]
   928 E C0022699:Kineses [Individual Behavior]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a thermodynamic inhibitor of amyloid formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "implication for the pathogenesis"

Phrase: "and"

Phrase: "treatment of Alzheimer's disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   881   C1979617:Alzheimer's disease treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.162: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.163: Natl. 

Phrase: "Natl."
Processing 00000000.tx.164: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.165: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.166: USA, 92, 763-767. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "92,"

Phrase: "763-767."
Processing 00000000.tx.167: MEDLINE Abstract 14. 

Phrase: "MEDLINE Abstract 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.168: Miyata, M. and Smith, J.D. 

Phrase: "Miyata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J.D."
Processing 00000000.tx.169: (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and [beta]-amyloid peptides. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E allele-specific antioxidant activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C1325281:apolipoprotein activity [Molecular Function]
   827   C1148564:antioxidant activity [Molecular Function]
   799   C0003402:Antioxidant [Pharmacologic Substance]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "effects on cytotoxicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "by oxidative insults"

Phrase: "and ["

Phrase: "beta]-amyloid peptides."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.170: Nature Genet., 14, 55-60. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "14,"

Phrase: "55-60."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]
Processing 00000000.tx.171: MEDLINE Abstract 15. 

Phrase: "MEDLINE Abstract 15."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.172: Strittmatter, W.J., Weisgraber, K.H., Goedert, M., Saunders, A.M., Huang, D., Corder, E.H., Dong, L.-M., Jakes, R., Alberts, M.J., Gilbert, J.R., Han, S.H., Hulette, C., Einstein, G., Schmechel, D.E., Pericak-Vance, M.A. and Roses, A.D. 

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Huang,"

Phrase: "D."

Phrase: ","

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Alberts,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Einstein,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.173: (1994) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease are related to Apolipoprotein E genotype. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: ":"

Phrase: "microtubule instability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1444783:Instability [Finding]

Phrase: "and"

Phrase: "paired helical filament formation in the Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "are"

Phrase: "related to Apolipoprotein E genotype."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.174: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.175: Neurol., 125, 163-171. 

Phrase: "Neurol.,"

Phrase: "125,"

Phrase: "163-171."
Processing 00000000.tx.176: MEDLINE Abstract 16. 

Phrase: "MEDLINE Abstract 16."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.177: Harr, S.D., Vint, L., Hollister, R., Hyman, B.T. and Mendez, A.J. 

Phrase: "Harr,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Vint,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hollister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "and"

Phrase: "Mendez,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.178: (1996) Brain expression of Apolipoprotein E, J and A-I in Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Brain expression of Apolipoprotein E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "J"

Phrase: "and"

Phrase: "A-I in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.179: J. 

Phrase: "J."
Processing 00000000.tx.180: Neurochem., 66, 2429-2435. 

Phrase: "Neurochem.,"

Phrase: "66,"

Phrase: "2429-2435."
Processing 00000000.tx.181: MEDLINE Abstract 17. 

Phrase: "MEDLINE Abstract 17."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.182: Lehtimki, T., Pirttil, T., Mehta, P.D., Wiesniewski, H.M., Frey, H. and Nikkari, T. 

Phrase: "Lehtimki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pirttil,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mehta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Wiesniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Frey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Nikkari,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.183: (1995) Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E (apoE) polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its influence on ApoE concentrations"

Phrase: "in the cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "in Finnish patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.184: Hum. 

Phrase: "Hum."
Processing 00000000.tx.185: Genet., 95, 39-42. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "95,"

Phrase: "39-42."
Processing 00000000.tx.186: MEDLINE Abstract 18. 

Phrase: "MEDLINE Abstract 18."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.187: Lefranc, D., Vermersch, P., Dallongeville, J., Daems-Monpeurt, C., Petit, H. and Delacourte, A. 

Phrase: "Lefranc,"

Phrase: "D."

Phrase: ","

Phrase: "Vermersch,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dallongeville,"

Phrase: "J.,"

Phrase: "Daems-Monpeurt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Petit,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Delacourte,"

Phrase: "A."
Processing 00000000.tx.188: (1996) Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Relevance of the quantification of apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "in the cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.189: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.190: Lett., 212, 91-94. 

Phrase: "Lett.,"

Phrase: "212,"

Phrase: "91-94."
Processing 00000000.tx.191: MEDLINE Abstract 19. 

Phrase: "MEDLINE Abstract 19."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.192: Taddei, K., Clarnette, R., Gandy, S.E. and Martins, R.N. 

Phrase: "Taddei,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Clarnette,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gandy,"

Phrase: "S."

Phrase: "E."

Phrase: "and"

Phrase: "Martins,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.193: (1997) Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Increased plasma apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(apoE) levels in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.194: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.195: Lett., 223, 29-32. 

Phrase: "Lett.,"

Phrase: "223,"

Phrase: "29-32."
Processing 00000000.tx.196: MEDLINE Abstract 20. 

Phrase: "MEDLINE Abstract 20."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.197: Nukina, N., Uchida, K., Sakamoto, T., Ide, K. and Kanazawa, I. 

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Uchida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.198: (1995) Monoclonal antibody against the polymorphic site distinguishes apolipoprotein [Egr]4 from other isoforms. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Monoclonal antibody against the polymorphic site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "distinguishes"

Phrase: "apolipoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[Egr"

Phrase: "]4 from other isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.199: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.200: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.201: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.202: Com., 216, 467-472. 

Phrase: "Com.,"

Phrase: "216,"

Phrase: "467-472."
Processing 00000000.tx.203: MEDLINE Abstract 21. 

Phrase: "MEDLINE Abstract 21."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.204: Ishimaru, H., Ishikawa, K., Haga, S., Shoji, M., Ohe, Y., Haga, C., Sasaki, A., Takashashi, A. and Maruyama, Y. 

Phrase: "Ishimaru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ishikawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Haga,"

Phrase: "S."

Phrase: ","

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Ohe,"

Phrase: "Y.,"

Phrase: "Haga,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sasaki,"

Phrase: "A.,"

Phrase: "Takashashi,"

Phrase: "A."

Phrase: "and"

Phrase: "Maruyama,"

Phrase: "Y."
Processing 00000000.tx.205: (1996) Accumulation of apolipoprotein E and b-amyloid-like protein in a trace of the hippocampal CA1 pyramidal cell layer after ischaemic delayed neuronal death, Neuroreport, 7, 3063-3067. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Accumulation of apolipoprotein E"

Phrase: "and"

Phrase: "b-amyloid-like protein in a trace"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0377800:b protein [Amino Acid, Peptide, or Protein,Receptor]
   774   C1336694:b-PROTEIN [Gene or Genome]
   774   C1455498:B-Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of the hippocampal CA1 pyramidal cell layer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C2717851:CA1 Pyramidal Cell Layer [Body Part, Organ, or Organ Component]
   804   C0934502:Layer [Body Part, Organ, or Organ Component]
   804   C1522408:Layer [Qualitative Concept]
   804   C1561599:Layer [Intellectual Product]

Phrase: "after ischaemic delayed neuronal death,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C2754100:neuron death [Cell Function]
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "Neuroreport,"

Phrase: "7,"

Phrase: "3063-3067."
Processing 00000000.tx.206: MEDLINE Abstract 22. 

Phrase: "MEDLINE Abstract 22."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.207: Templeton, A.R. 

Phrase: "Templeton,"

Phrase: "A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.208: (1995) A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. 

Phrase: "(1995"

Phrase: ")"

Phrase: "A cladistic analysis of phenotypic associations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "with haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "inferred from restriction endonuclease mapping"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0035269:Endonuclease Mapping, Restriction [Laboratory Procedure,Molecular Biology Research Technique]
           Restriction Mapping
   806   C0012906:Restriction Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443288:Restriction [Functional Concept]
   760   C0679201:Inferred [Mental Process]
   760   C1283195:Mapping [Activity]
   760   C3245504:inferred [Idea or Concept]

Phrase: "or"

Phrase: "DNA sequencing."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162326:DNA sequencing [Nucleotide Sequence]
  1000   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.209: V. 

Phrase: "V."
Processing 00000000.tx.210: Analysis of case/control sampling designs: Alzheimer's disease and the Apolipoprotein E locus. 

Phrase: "Analysis of case/control sampling designs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1303103:Sample analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the Apolipoprotein E locus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708726:Locus [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.211: Genetics, 140, 403-409. 

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "140,"

Phrase: "403-409."
Processing 00000000.tx.212: MEDLINE Abstract 23. 

Phrase: "MEDLINE Abstract 23."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0450348:23 [Quantitative Concept]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.213: Hixon, J.E. and Vernier, D.T. 

Phrase: "Hixon,"

Phrase: "J.E."

Phrase: "and"

Phrase: "Vernier,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.214: (1991) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Restriction isotyping of human apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by gene amplification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017256:Gene Amplification [Genetic Function]
  1000   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   861   C0017337:Gene [Gene or Genome]
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]

Phrase: "and"

Phrase: "cleavage with HhaI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]
Processing 00000000.tx.215: J. 

Phrase: "J."
Processing 00000000.tx.216: Lipid Res., 31, 545-548. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "545-548."
Processing 00000000.tx.217: 24. 

Phrase: "24."
Processing 00000000.tx.218: Gilmour, R.S. and Dixon, G.H. 

Phrase: "Gilmour,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Dixon,"

Phrase: "G.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.219: (1972) Biosynthesis of protamine in trout testis. 

Phrase: "(1972"

Phrase: ")"

Phrase: "Biosynthesis of protamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005572:biosynthesis [Functional Concept]
   790   C0220781:Biosynthesis [Biologic Function]

Phrase: "in trout testis."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0039597:Testis [Body Part, Organ, or Organ Component]
   861   C1278981:Testis [Body Part, Organ, or Organ Component]
   777 E C0021358:Testes [Body Part, Organ, or Organ Component]
   768 E C0205070:Testicular [Spatial Concept]
   750 E C1284096:Testicle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.220: J. 

Phrase: "J."
Processing 00000000.tx.221: Biol. 

Phrase: "Biol."
Processing 00000000.tx.222: Chem., 247, 4621-4627. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "247,"

Phrase: "4621-4627."
Processing 00000000.tx.223: MEDLINE Abstract *To whom correspondence should be addressed at: INSERM CJF95-05, Institut Pasteur de Lille, 1 rue de Calmette, 59019 Lille Cedex, France. 

Phrase: "MEDLINE Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "INSERM CJF95-05,"

Phrase: "Institut Pasteur de Lille,"

Phrase: "1 rue de Calmette,"

Phrase: "59019 Lille Cedex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0591239:Cedex [Antibiotic,Organic Chemical]

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.224: Tel: +33 3 20 87 72 28; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+33 3 20 87 72 28"

Phrase: ";"
Processing 00000000.tx.225: Fax: +33 3 20 87 78 94; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+33 3 20 87 78 94"

Phrase: ";"
Processing 00000000.tx.226: Email: marie-christine.chartier-harlin@pasteur-lille.fr This page is maintained by OUP admin. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "marie-christine.chartier-harlin@pasteur-lille.fr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C2348513:Fr. [Conceptual Entity]
   795   C3538902:FR [Gene or Genome]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "maintained by OUP admin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
Processing 00000000.tx.227: Last updated Sat Oct 18 13:41:19 BST 1997. 

Phrase: "Last updated Sat Oct 18 13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1517741:Last [Qualitative Concept]
   799   C1705827:SAT [Gene or Genome]
   766   C1519814:Update [Temporal Concept]

Phrase: ":"

Phrase: "41"

Phrase: ":"

Phrase: "19 BST 1997."
Processing 00000000.tx.228: Part of the OUP Journals World Wide Web service. 

Phrase: "Part of the OUP Journals World Wide Web service."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.229: Copyright Oxford University Press, 1997

Phrase: "Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "1997"

